Agilent Technologies (A) : $15.92 million worth of transactions were on upticks in Agilent Technologies (A), compared to $7.74 million on downticks. The ratio between the two was 2.06, whereas, the net money flow stood at a healthy $8.17 million on Fridays session. The consistent buying on upticks in the stock accounted for $8.15million worth of trades. The total money flow into the stock stood at $8.15 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.19%. The stock was trading at $46.58, with a drop of $0.09 over the previous days close. The stock recorded -0.19% for the week.
Agilent Technologies (A) : 8 investment research analysts covering Agilent Technologies (A) have an average price target of $49.38 for the near short term. The highest target price given by the Brokerage Firm to the stock is $55 and the lowest target is $45 for the short term. Analysts expect the variance to be within $3.02 of the average price.
Agilent Technologies (NYSE:A): On Fridays trading session , Opening price of the stock was $46.72 with an intraday high of $46.79. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $46.42. However, the stock managed to close at $46.58, a loss of 0.19% for the day. On the previous day, the stock had closed at $46.67. The total traded volume of the day was 1,512,440 shares.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director of Agilent Technologies Inc, Cullen James had sold 16,697 shares worth of $764,389 in a transaction dated May 27, 2016. In this transaction, 16,697 shares were sold at $45.78 per share.
Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.